Overview

Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine: - The safety of duloxetine and any side effects that might be associated with it. - How duloxetine compares to escitalopram and placebo (an inactive ingredient)
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Citalopram
Dexetimide
Duloxetine Hydrochloride